Tag: Japan Congestive Heart Failure (CHF) Treatment Devices market 2019

Global Congestive Heart Failure (CHF) Treatment Devices market is valued at 11 Billion US$ in 2018 is expected to reach 17.2 Billion US$ by the end of 2025, growing at a CAGR of 5.7% during 2019-2025 | Industry Leaders Covered | Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Medtronic, ReliantHeart, St. Jude Medical|

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body…
Read more